Table 4.
UVA | MVA† | |||||||
---|---|---|---|---|---|---|---|---|
OS | PFS | OS | PFS | |||||
HR (CI‡) | p-value | HR (CI‡) | p-value | HR (CI‡) | p-value | HR (CI‡) | p-value | |
Basophils ≥ 0.1 (Above) vs. <0.1 (Below optimal cut) | 3.69 (1.91–7.12) | <0.001 | 2.39 (1.42–4.01) | 0.001 | 3.51 (1.65–7.43) | 0.001 | 1.88 (1.05–3.38) | 0.034 |
BLR ≥ 0.0142 (Above) vs. < 0.0142 (Below optimal cut) | 1.35 (0.73–2.50) | 0.338 | 0.76 (0.51–1.14) | 0.187 | 2.11 (1.09–4.10) | 0.028 | 0.87 (0.55–1.35) | 0.526 |
The MVA was built in Cox proportional hazard model by controlling for drug, race, age at diagnosis, disease volume, ECOG, and Gleason.
95% confidence interval
BLR = basophil-to-lymphocyte ratio